Glucagon antagonists/inversion agonists

Saved in:
Bibliographic Details
Main Authors MADSEN PETER, JOHNSON MICHAEL DAVID, NAERUM LARS, GREGOR VLAD, SAMS CHRISTIAN, TESTON KIMBERLY ANN, LING ANTHONY, KIEL DAN, SHI SHENGHUA, SIDELMANN ULLA GROVE, TENG MIN, LAU JESPER, FENG JUN, PLEWE MICHAEL BRUNO, KNUDSEN LOTTE BJERRE, GONZALES JAVIER, HONG YUFENG, KUKI ATSUO
Format Patent
LanguageCzech
English
Published 12.07.2000
Edition7
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Author SHI SHENGHUA
GONZALES JAVIER
JOHNSON MICHAEL DAVID
FENG JUN
LING ANTHONY
HONG YUFENG
PLEWE MICHAEL BRUNO
KIEL DAN
KUKI ATSUO
KNUDSEN LOTTE BJERRE
MADSEN PETER
SIDELMANN ULLA GROVE
LAU JESPER
GREGOR VLAD
SAMS CHRISTIAN
TESTON KIMBERLY ANN
NAERUM LARS
TENG MIN
Author_xml – fullname: MADSEN PETER
– fullname: JOHNSON MICHAEL DAVID
– fullname: NAERUM LARS
– fullname: GREGOR VLAD
– fullname: SAMS CHRISTIAN
– fullname: TESTON KIMBERLY ANN
– fullname: LING ANTHONY
– fullname: KIEL DAN
– fullname: SHI SHENGHUA
– fullname: SIDELMANN ULLA GROVE
– fullname: TENG MIN
– fullname: LAU JESPER
– fullname: FENG JUN
– fullname: PLEWE MICHAEL BRUNO
– fullname: KNUDSEN LOTTE BJERRE
– fullname: GONZALES JAVIER
– fullname: HONG YUFENG
– fullname: KUKI ATSUO
BookMark eNrjYmDJy89L5WRQd88pTU5Mz89TSMwrAdGZxSXF-pl5ZalFxZkgUagQDwNrWmJOcSovlOZmkHdzDXH20E0tyI9PLS5ITE7NSy2Jd44yMTEzt7R0NDYmrAIAMc4pww
ContentType Patent
DBID EVB
DatabaseName esp@cenet
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate Glukagonoví antaginisté/inverzní agonisté
Edition 7
ExternalDocumentID CZ446799A3
GroupedDBID EVB
ID FETCH-epo_espacenet_CZ446799A33
IEDL.DBID EVB
IngestDate Fri Jul 19 16:19:17 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Czech
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CZ446799A33
Notes Application Number: CZ19990004467
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20000712&DB=EPODOC&CC=CZ&NR=446799A3
ParticipantIDs epo_espacenet_CZ446799A3
PublicationCentury 2000
PublicationDate 20000712
PublicationDateYYYYMMDD 2000-07-12
PublicationDate_xml – month: 07
  year: 2000
  text: 20000712
  day: 12
PublicationDecade 2000
PublicationYear 2000
RelatedCompanies NOVO NORDISK A/S
AGOURON PHARMACEUTICALS, INC
RelatedCompanies_xml – name: AGOURON PHARMACEUTICALS, INC
– name: NOVO NORDISK A/S
Score 2.5089786
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Glucagon antagonists/inversion agonists
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20000712&DB=EPODOC&locale=&CC=CZ&NR=446799A3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUk2TU0EHT5oapGUBDpUO1HXwtQkRdfAxDwpKdXcxCDVFLR32NfPzCPUxCvCNIKJIQO2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqowXrHoBrTSM3FydY1wN_F31nN2dnWOUrNL8gW2Osxt7R0NGZmYAU1okGn7LuGOYH2pBQgVyhuggxsAUCz8kqEGJiSi4UZOJ1h964JM3D4Qqe7gUxozisWYVB3B11Plp6fpwAMChANVF2sn5lXBhnvUoAJiTLIu7mGOHvoAm2Mh3su3jkK5jRjMQYWYJc_VYJBISnZJC0pMRk0pWhskpJmYWGWaJgEOiglzdw0MTUpUZJBApcpUrilpBm4IBvJzXUNjWQYWEqKSlNlgVVqSZIcODQAiHh8nQ
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUk2TU0EHT5oapGUBDpUO1HXwtQkRdfAxDwpKdXcxCDVFLR32NfPzCPUxCvCNIKJIQO2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqowXrHoBrTSM3FydY1wN_F31nN2dnWOUrNL8gW2Osxt7R0NGZmYDUHnc0LajiFOYH2pBQgVyhuggxsAUCz8kqEGJiSi4UZOJ1h964JM3D4Qqe7gUxozisWYVB3B11Plp6fpwAMChANVF2sn5lXBhnvUoAJiTLIu7mGOHvoAm2Mh3su3jkK5jRjMQYWYJc_VYJBISnZJC0pMRk0pWhskpJmYWGWaJgEOiglzdw0MTUpUZJBApcpUril5Bk4PUJ8feJ9PP28pRm4IJvKzXUNjWQYWEqKSlNlgdVrSZIcOGQAhJ1_ig
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Glucagon+antagonists%2Finversion+agonists&rft.inventor=MADSEN+PETER&rft.inventor=JOHNSON+MICHAEL+DAVID&rft.inventor=NAERUM+LARS&rft.inventor=GREGOR+VLAD&rft.inventor=SAMS+CHRISTIAN&rft.inventor=TESTON+KIMBERLY+ANN&rft.inventor=LING+ANTHONY&rft.inventor=KIEL+DAN&rft.inventor=SHI+SHENGHUA&rft.inventor=SIDELMANN+ULLA+GROVE&rft.inventor=TENG+MIN&rft.inventor=LAU+JESPER&rft.inventor=FENG+JUN&rft.inventor=PLEWE+MICHAEL+BRUNO&rft.inventor=KNUDSEN+LOTTE+BJERRE&rft.inventor=GONZALES+JAVIER&rft.inventor=HONG+YUFENG&rft.inventor=KUKI+ATSUO&rft.date=2000-07-12&rft.externalDBID=A3&rft.externalDocID=CZ446799A3